Xconomy | Life Sciences - Business + Technology in the Exponential Economy

News Xpress

San Diego
Wireless Health, people, Life Sciences

West Wireless Health Institute Names J&J Exec as First CEO

Bruce V. Bigelow 3/9/10

San Diego’s West Wireless Health Institute today named Donald Casey as its first chief executive officer. Case, a former worldwide chairman of Johnson & Johnson’s Comprehensive Care group, also will serve on the institute’s board of directors, according to a statement issued today.

Gary West, who sold his Omaha, NE-based West Corp. for $3.3 billion in 2006, founded the institute almost exactly a year ago with a $45 million gift from... Read more »

Comments | Reprints | Share:

San Diego
Biotech, people, startups

The 20-Year Future of San Diego Biotech, Coming March 31

Luke Timmerman 3/9/10

A wise man once said that overnight success in biotech takes about 15 years. All kidding aside, we at Xconomy recognize that real innovation in life sciences doesn’t just pop out of the blue on a... Read more »

Comments | Reprints | Share:

Seattle
Roundup, deals, VC

Google Buys DocVerse, Madrona Backs ShopIgniter, ISB Gets Mystery Gift, & More Seattle-Area Deals News

Gregory T. Huang 3/9/10

In the week since Google’s acquisition of Picnik, the Northwest deals scene came back to earth a little bit. But there was a decent amount of activity in software, Internet, mobile, and cleantech, much of it... Read more »

Comments | Reprints | Share:

San Diego
Life Sciences, innovation, Drug Development

Scientists from Sapphire Energy, UCSD, Scripps, and Protelica Show Genetically Modified Algae Can Make Important Drugs

Bruce V. Bigelow 3/8/10

Scientists in San Diego and Hayward, CA, have demonstrated the feasibility of using algae to produce commercial levels of human therapeutic proteins that are currently being used to treat emphysema and other diseases, or are in... Read more »

Comments (4) | Reprints | Share:

Boston
Biotech, Hepatitis C, Drugs

Vertex Maps Out Combo Drug Game Plan for Treating Hepatitis C

Luke Timmerman 3/8/10

HIV has taught the pharmaceutical industry that the best way to fight an infectious virus that resists a single drug is to make a cocktail that attacks the virus in more than one way. Vertex Pharmaceuticals... Read more »

Comments (1) | Reprints | Share:

Seattle
Biotech, cancer, IT

Dendreon Leans on California 9-1-1 Software Vendor to Keep Provenge Trains on Time

Luke Timmerman 3/8/10

If Dendreon makes any information technology screw-ups with its experimental treatment for prostate cancer, it could be a matter of life and death for patients. That’s why the Seattle-based biotech company has turned to a custom... Read more »

Comments | Reprints | Share:

Seattle
Biotech, cancer, Drugs

Cell Therapeutics Offers Execs Big Cash Bonuses As Stock Trades Below a Buck

Luke Timmerman 3/5/10

Comments (12) | Reprints | Share:

San Diego
Biotech, Finances, Antibiotics

Trius Puts the Brakes on IPO Plan, While It Adjusts to New FDA Clinical Guidelines

Luke Timmerman 3/5/10

Comments | Reprints | Share:

San Diego
Life Sciences, medical devices, Obstructive Sleep Apnea

ImThera Medical Generating Buzz Over Neurostimulation for Sleep Apnea

Bruce V. Bigelow 3/5/10

Comments | Reprints | Share:

Seattle
Biotech, Devices, Ultrasound

Ekos, Swedish Aim to Shake Up Stroke Treatment with Ultrasound Brain Clot Buster

Luke Timmerman 3/5/10

Comments | Reprints | Share:

Boston
Life Sciences, deals, Diagnostics

Una Ryan Searching for Riches to Deliver Inexpensive Diagnostics to the Poor

Ryan McBride 3/5/10

Comments | Reprints | Share:

Boston
Roundup, Life Sciences, Biotech

Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News

Erin Kutz 3/5/10

Comments | Reprints | Share:

Xconomist Forum - Insight & Opinion

Seattle
Biotech, Drugs, startups

The Pharmaceutical R&D Model is Broken. Here’s How to Fix It

Stewart Lyman 3/5/10

Research is the lifeblood of the biotech and pharmaceuticals business. The pharma and biotech industry spent some $65 billion dollars on R & D in 2008, according to the Pharmaceutical Research... Read more »

Comments (5) | Reprints | Share:

Seattle
Biotech, people, careers

Tips on How Academic Scientists Can Make the Career Switch to Industry

Don Rule 2/25/10

Scientists have a lot to consider if they want to leave the world of academia for a job in industry. I picked up a lot of good insights yesterday at a... Read more »

Comments (1) | Reprints | Share:

San Diego
Mobile Handsets, cleantech, startups

How EcoATM Became San Diego’s Hottest Startup Deal, If I Say So Myself

Mark Bowles 2/17/10

For a company that was founded by three wireless industry veterans only about a year ago, ecoATM ended 2009 with some pretty impressive results. If there was a yearbook for San... Read more »

Comments (8) | Reprints | Share:

San Diego
Life Sciences, Jobs, Economy

Why Biomedical Jobs Are Recession Resilient

David Gollaher 2/12/10

Biomedical employment has held remarkably steady in San Diego and throughout California, even though other parts of our economy saw steep declines and the highest unemployment levels since the Great Depression.... Read more »

Comments (4) | Reprints | Share:

Seattle
Biotech, people, Global Health

Why Biotech Innovators Are Beating a Path to Seattle

Chris Rivera 2/12/10

As the life sciences sector continues to navigate the changing seas of innovation in the new economy, we’ve trained our gaze toward a few beacons. Seattle and the Pacific Northwest have... Read more »

Comments | Reprints | Share:

Boston
IPOs, law, management

Ready, Set, Go Public—The 10 Things You Need to Do Now

David Westenberg 2/11/10

The IPO market is open for business. The IPO market window has slammed shut. Which is it? Unless your IPO is pricing in the next week or two, it doesn’t matter.... Read more »

Comments (1) | Reprints | Share: